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Abstract
A major problem in gene therapy is the determination of the rates at which
gene transfer has occurred. Our work has focused on applications of the
Sleeping Beauty (SB) transposon system as a non-viral vector for gene therapy.
Excision of a transposon from a donor molecule and its integration into a
cellular chromosome are catalyzed by SB transposase. In this study, we used
a plasmid-based excision assay to study the excision step of transposition.
We used the excision assay to evaluate the importance of various sequences
that border the sites of excision inside and outside the transposon in order to
determine the most active sequences for transposition from a donor plasmid.
These findings together with our previous results in transposase binding to the
terminal repeats suggest that the sequences in the transposon-junction of SB
are involved in steps subsequent to DNA binding but before excision, and that
they may have a role in transposase–transposon interaction. We found that
SB transposons leave characteristically different footprints at excision sites
in different cell types, suggesting that alternative repair machineries operate
in concert with transposition. Most importantly, we found that the rates
of excision correlate with the rates of transposition. We used this finding to
assess transposition in livers of mice that were injected with the SB transposon
and transposase. The excision assay appears to be a relatively quick and easy
method to optimize protocols for delivery of genes in SB transposons to
mammalian chromosomes in living animals. Copyright  2004 John Wiley &
Sons, Ltd.
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Introduction
Tc1/mariner transposons are a large family of DNA transposable elements.
They are widespread in nature and can be found in virtually all animal phyla
[1,2]. Recently, we reconstructed a synthetic Tc1-like vertebrate transposon
system called Sleeping Beauty (SB) from inactive salmonid fish elements
by a comparative phylogenetic approach [3]. In mammalian cells, the SB
transposon system is an order of magnitude more efficient than other
Tc1 family members tested [4]. Since its discovery, SB has been used in
a wide range of vertebrate systems [5] for functional genomics [6–8],
germ-line transgenesis [4,6,9], and somatic integration [10–12]. Its higher
efficiency compared to other DNA-based transposable elements, its ability to
accommodate large genetic cargoes [5,13], and its presumed safety compared
to viral vectors make SB a potentially powerful tool for human gene therapy.
The SB transposon system consists of two parts – the transposon, consisting
of inverted terminal repeats (ITRs), and the SB transposase that catalyzes the
mobilization of the transposon. Like other members of the Tc1/mariner
Copyright  2004 John Wiley & Sons, Ltd.
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transposon family, SB transposons are mobilized via a cut-
and-paste mechanism (Figure 1A). There are two major
steps involved in transposition, the excision of the trans-
poson from the donor site and the integration of the
transposon into the target site [2]. Excision from the donor
site involves staggered, double-stranded DNA breaks at
each side of the transposon, which result in a small num-
ber of nucleotides at the termini of the transposon being
left behind [2,14]. The majority of Tc1/mariner trans-
posons integrate into TA-dinucleotide base pairs in a fairly
random manner [8,9,15]. As a result of the staggered cut
at the TA target sites, the transposons are flanked by TA-
dinucleotides on both sides after integration (Figure 1B),
a phenomenon called target-site duplication [2,3].
The ITRs of the current SB transposon came from
a single Tc1-like element from a salmonid, Tanichthys
albonuibes – referred to as T. T has two inverted repeats
(IRs) at its termini and two ‘direct repeats’ (DRs) within
each IR (Figure 1A). The outer DRs, Lo and Ro, are
located at the left and right termini of the transposon,
respectively, and the inner DRs, Li and Ri, are located
further inside the transposon. Both DRs contain binding
sites for SB transposase [3] and the middle 18 bp within
the DRs have been suggested to comprise a minimal core
sequence for transposase binding [16]. Both the outer and
inner DRs are required for efficient transposition [3], but
they are not interchangeable, indicating that their roles
in transposition are different [16].
B
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Figure 1. The Sleeping Beauty (SB) transposon and its
transposition. (A) Structure of the terminal repeats of the SB
transposon. The DRs of the ITRs are designated by arrowheads
and are labeled according to their positions in the transposons
used in this study. The boxed TAs flanking the transposon
result from duplication of the original TA insertion site.
(B) ‘‘Cut-and-paste’’ mechanism of SB transposition revised
from Luo et al. [14] and Plasterk et al. [2]. The two major
steps involved in transposition, excision and integration of a
transposon are shown. The two broken ends at the donor sites,
joined together by non-homologous end-joining (NHEJ) enzymes
encoded by the host, leave a footprint at the donor site
PCR-based excision analysis has been used to detect
excision from a chromosomal location by SB transposase
[4,7,9,14]. However, this method is not suitable for
studying the mechanism of transposition because the
excision is limited to a particular transposon and a
particular donor site in the chromosomal position.
Plasmid-based excision assays, on the other hand, are
more versatile and easier to perform [18,19]. Hence,
we developed a plasmid-based excision assay for the
SB transposon system to study the different steps of
transposition in more detail and found a correlation
between the excision rate and the transposition rate.
Using this assay, we analyzed the footprints of SB in
tissue-cultured cells as well as in zebrafish embryos and
mice. The results of these studies directed design of a
better transposon as well as led to the development of
a method for determining transposition from a plasmid
in organs of mice. This latter assay should be extremely
useful for optimizing SB-mediated transposition reactions
in mammals as a step towards harnessing the transposon
for gene therapy. In such procedures, a gene contained in
a transposon vector is prepared at high concentrations in
a plasmid that is then delivered by any of several methods
to a target organ. As a result, the sequence of the donor
plasmid can serve as a common site for monitoring the
excision step of the transposition reaction.
Materials and methods
Plasmids
The maps and sequences for plasmids pCMVSB (also
called pSB10) and pSB10-DDE, which contain an active
and inactive transposase gene, respectively, and pT/neo
which contains a transposon [3] as well as pT/HindIIIneo
(Adam Dupuy, unpublished) can be found through
our website [20]. We name pT/HindIIIneo variants
by the DRs that are in their left and right IRs. All
variant pT/HindIIIneo constructs were made by PCR-
mediated, site-directed mutagenesis described previously
for LoLi–LiLo, RoRi–RiRo, LiLi–RiRo and LoLo–RiRo
[16]. Mutagenic primers SacI + Lo and BamHI + Ro
were used to amplify complete variant transposons on
pT/HindIIIneo. After digesting with SacI and BamHI, the
PCR fragments were ligated into the SacI/BamHI vector
fragment of pT/HindIIIneo. All constructs were confirmed
by sequencing.
Mutagenic primers we used are listed below with
specific mutations underlined:
SacI + Lo (AAA): TTGGAGCTCGGTACCCTAAAATTGAA-
GTC
SacI + Lo (CAA): TTGGAGCTCGGTACCCTACAATTGAA-
GTC
SacI + Lo (AAG): TTGGAGCTCGGTACCCTAAAGTTGAA-
GTC
BamHI + Ro (AAA): AGCTAGAGGATCCCCTAAAATTGA-
AGTCG
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BamHI + Ro (CAA): AGCTAGAGGATCCCCTACAATTGA-
AGTCG
BamHI + Ro (AAG): AGCTAGAGGATCCCCTAAAGTTGA-
AGTCG
BamHI + Ro (CC): AGCTAGAGGATCCCCCCCAGTTGAA-
GTCG
SacI + Lo (GG): TTGGAGCTCGGTACCCGGCAGTTGAA-
GTC
Plasmid-based excision analysis
Excision in HeLa cells: 500 ng pT/neo or pT/HindIIIneo
mutation constructs were co-transfected with 100 ng
pCMVSB (or pSB10-DDE) into 3 × 105 HeLa cells. Four
days post-transfection, cells were collected and lysed in
200 µl lysis buffer [50 mM KCl, 10 mM Tris-HCl (pH
8.3), 2.5 mM MgCl2, 10 mM EDTA, 0.45% (w/v) NP40,
0.45% (w/v) Tween-20, 100 µg/ml Proteinase K] and
incubated at 55 ◦C for 2–3 h followed by 95 ◦C for 20 min
to inactivate the Proteinase K. For temporal analyses, 5 µl
of lysate were added to the PCR mixture [1 × NH4 PCR
buffer, 3 mM MgCl2, 0.2 mM dNTP, 10 pmol forward and
reverse primer each, 0.5 µl Biolase, buffer and enzyme
from Bioline USA]. The PCR conditions were as follows:
94 ◦C for 5 min, 60 cycles of (94 ◦C 30 s, 64 ◦C 30 s,
72 ◦C 20 s), followed by 72 ◦C for 10 min. Five µl of
1/50 dilution of the above PCR product were used for
the second round PCR using nested primers and 1.5 mM
MgCl2; the composition of the PCR mixture was otherwise
the same. Nested PCR was performed at 94 ◦C for 5 min,
35 cycles of (94 ◦C 30 s, 64 ◦C 30 s, 72 ◦C 5 s), followed by
72 ◦C for 10 min. For pT/neo, only one round of PCR was
performed and gave products of about 582 bp. Primers
were:
o-lac-L: 5′-GGCTGGCTTAACTATGCGGCATCAG-3′
o-lac-R: 5′-GTCAGTGAGCGAGGAAGCGGAAGAG-3′
For pT/HindIIIneo and its mutation constructs, nested
PCR gave products of about 316 bp. Primers were:
1st round: F1-ex: 5′-CCAAACTGGAACAACACTCAAC-
CCTATCTC-3′
o-lac-R: 5′-GTCAGTGAGCGAGGAAGCGGAAGAG-3′.
2nd round: KJC031: 5′-CGATTAAGTTGGGTAACGCCAG-
GGTTT-3′
i-lac-R: 5′-AGCTCACTCATTAGGCACCCCAGGC-3′.
Excision in zebrafish embryos: 25 ng/µl pT/neo was
co-injected with 25 ng/µl SB mRNA into one-cell-stage
zebrafish embryos. SB transposase mRNA was synthesized
by in vitro transcription using the Message Machine large-
scale in vitro transcription kit (Ambion). The injection
volume for each embryo was 1–3 nl. Twenty-four hours
after injection, single embryos were lysed in 50 µl
lysis buffer [10 mM EDTA, 10 mM Tris-HCl (pH 8.0),
200 µg/ml Proteinase K] as described [18,19] for 3 h at
50 ◦C, followed by 20 min incubation at 95 ◦C to inactivate
the Proteinase K; 2 µl of embryo lysate were used for PCR.
The program used for PCR was as follows: 94 ◦C 5 min,
30 cycles of (94 ◦C 30 s, 67 ◦C 30 s), 25 cycles of (94 ◦C
for 30 s, 67 ◦C for 30 s, 72 ◦C for 5 s) followed by 72 ◦C
for 10 min.
Excision in mouse liver: DNA was isolated from
8 mm3 frozen liver specimens using the Puregene DNA
purification kit (Gentra Systems, Minneapolis, MN, USA).
PCR was performed in two rounds of amplification. PCR I
was carried out in a 50-µl reaction mixture containing 1 µg
DNA, 5% DMSO, 5% glycerol, 10 pmol each forward and
reverse primer, a 0.2 mM concentration of each dNTP,
1× PCR buffer A (Invitrogen, Carlsbad, WI, USA), and
5U Taq DNA polymerase (Promega, Madison, WI, USA).
PCR conditions were: 95 ◦C for 5 min followed by 45
cycles of (95 ◦C, 40 s, 58 ◦C, 30 s, 72 ◦C for 1 min) with
the final extension of 5 min at 72 ◦C. A 10-µl aliquot
of the primary PCR product was used for secondary
amplification in a 100-µl reaction with nested primers
(10 µm concentration) and the same cycling conditions
except that the number of cycles was 35. The expected
size of the amplified excision product was approximately
456 bp. The primers used for the excision assay were
outside left and right ITRs. The primer sequences were:
FP1: 5′-TGACGTTGGAGTCCACGTTC-3′
RP1: 5′-GGCTCGTATGTTGTGTGG-3′
FP2: 5′-CTGGAACAACACTCAACCCT-3′
RP2: 5′-CACACAGGAAACAGCTATGA-3′.
Detection and quantification of the PCR
product
The excision PCR products were separated on 3% low-
melt gels (GenePure Sieve GQA agarose, ISC Bioexpress)
and stained with 50 µg/ml ethidium bromide. For
better resolution and quantification, PCR products were
separated on 6% polyacrylamide gels and stained with
1 : 10 000 dilution of SYBR green I (Molecular Probes,
Inc.) for 45 min. The gels were scanned with a Storm
phosphor imager (Molecular Dynamics) at 850 V in
the blue fluorescence mode to visualize the bands. To
standardize the input total plasmid DNA for each PCR,
a 1/5000 dilution of initial lysate was used to amplify
a segment of the ampicillin-resistance gene on both
pCMVSB and input pT transposon plasmid (depending
on the experiment, it could be pT/HindIIIneo, one of
the mutants, or pT/neo). These products were separated
on 1% agarose gel and stained with 50 µg/ml ethidium
bromide. The intensity of each band was measured in
arbitrary increments of density units (integrated optical
density, IOD) using Gel-Pro analyzer imaging software
(Media Cybernetics). The background was corrected using
the filtered profile method, as instructed in the manual.
The relative excision activity of the mutated transposon
constructs was derived from their standardized IOD, i.e.,
the IOD of the excision band divided by the relative
input template. The relative excision activity is indicated
as a percentage of the excision activity of the control
transposon pT/HindIIIneo, for which a standard curve
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derived from the ratio of the different dilutions of the
transposon was constructed.
Footprint sequencing
To sequence the footprint, the PCR products were gel-
extracted (for mutations with low excision activity,
reamplified with the nested PCR), cloned into the TOPO
TA cloning vector (Invitrogen) and sequenced by the
Advanced Genetics Analysis Center at the University of
Minnesota.
Transposon delivery to mouse liver
The transposon-containing plasmid pT/CAGGS-GUSB
(transposon) and the transposase-expressing plasmid
pCMVSB were used to assay transposition in adult
mouse tissues (Aronovich et al., manuscript in prep.). The
transposon contains an expression cassette for the GUSB
gene to restore activity to mutant mice deficient in β-
glucuronidase activity. The mucopolysaccharidosis (MPS)
type VII mice (B6.C-H-2bml/ByBir-gusmps) were obtained
from Jackson Laboratories (Bar Harbor, ME, USA) and
maintained in the AAALAC-accredited specific pathogen-
free mouse facility at the University of Minnesota. The
plasmids were injected into the tail vein of homozygous
12–16-week-old MPS VII mice using a 3-ml latex-free
syringe with a 271/2G needle. The hydrodynamics-based
procedure was performed as described [21,22]. Each
mouse received plasmid DNA in lactated Ringer’s solution
in a total volume equal to 10% of body weight. 25 µg
of a single preparation of transposon pT/CAGGS-GUSB
were injected either alone (‘Treatment Group 1’), or with
pCMVSB at 10 : 1 transposon/transposase molar ratio
(‘Treatment Group 2’). 37.5 µg DNA were injected into
all mice with pBluescript plasmid as a ‘filler’; the sham
treatment control group of MPS VII mice was injected
with pBluescript alone. All injections were performed only
once. The mice were euthanized 1-week post-injection,
livers were harvested and frozen at −80 ◦C. Excision
assays were performed as described above.
Results
Assay for the excision step of
transposition
We developed and used the excision assay first in HeLa
cells where we co-transfected the transposon plasmid
pT/neo and the transposase-expressing plasmid pCMVSB
(Figure 2). Three days after transfection, the plasmids
in the cell lysate were used as templates for PCR.
Using primers flanking the donor sites, we detected
excision by amplifying a PCR product that corresponded
to the size of a rejoined vector after the excision of the
transposon. As shown in Figure 3A, a PCR product of
Figure 2. Schematic of the excision assay. Plasmids containing
a transposon and CMVSB transposase were co-transfected
into HeLa cells. Four days post-transfection, cell lysates were
obtained and used for PCR with primers flanking the donor sites.
The PCR products were sequenced to determine the footprints
of the excision. The procedure is shown on the left and the state
of the transposon and its excision product is shown on the right
approximately 582 bp was amplified in cell lysates from
a pCMVSB and pT/neo co-transfection. The PCR product
appeared to be specific to SB excision because neither
pSB-DDE, which has a mutated catalytic domain, the
transposon plasmids alone, nor the transposase plasmids
alone, produced the 582-bp product. Figure 3B shows the
accumulation of the excision products over several days.
Excision products were detectable 18 h after transfection
and their levels continued to rise through 89 h after
transfection. In subsequent experiments, we collected
samples at 72 h for quantification of excision events
under different conditions. Figure 3C shows the same
excision assay carried out in zebrafish embryos. We
co-injected transposon plasmids and SB mRNA as the
source of the transposase. Extracts of 24-h embryos were
used for analysis of excision by PCR. As with the cell
cultures, excision was evident only in the presence of SB
transposase, which supports our previous findings [9].
Footprints of SB excision
We cloned and sequenced the excision PCR products
to study the footprints left by the transposons. Table 1
shows the summary of the footprint sequences acquired
from HeLa cells and zebrafish embryos. The two flanking
sides of the transposon had footprints of varying lengths
that we categorized in one of three ways – canonical
footprint, non-canonical footprint, gap/insertion. Canon-
ical footprints had 7-bp sequences TACAGTA or TACT-
GTA conforming to the model illustrated in Figure 1B
(5-bp insertions of either CAGTA or CTGTA following
Copyright  2004 John Wiley & Sons, Ltd. J Gene Med 2004; 6: 574–583.
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Table 1. Footprint sequences from HeLa cells and zebrafish embryos
Systems Category Left-flanking Footprint Right-flanking Events
HeLa cells Canonical footprints TTCGAGCTCGGTACCC TA CAG TA GGGGATCCTCTAGAGT 4
TTCGAGCTCGGTACCC TA CTG TA GGGGATCCTCTAGAGT 2
Non-canonical footprints TTCGAGCTCGGTACCC T G TA GGGGATCCTCTAGAGT 3
TTCGAGCTCGGTACCC TA TA GGGGATCCTCTAGAGT 2
TTCGAGCTCGGTACCC TA C TA GGGGATCCTCTAGAGT 1
TTCGAGCTCGGTACCC T TG TA GGGGATCCTCTAGAGT 1
TTCGAGCTCGGTACCC TA C A GGGGATCCTCTAGAGT 1
Gaps (82-bp deletion) G TA GGGGATCCTCTAGAGT 1
(67-bp deletion) (89bp deletion) 1
Insertions TTCGAGCT TGCATGTGGGAGGTTTTTTC GGATCCTCTANAGT 1
Zebrafish embryos Canonical footprints TTCGAGCTCGGTACCC TA CTG TA GGGGATCCTCTAGAGT 5
TTCCAACNCGGTACCC TA CAG TA GGGAATCCTCTAGAGT 4
Gaps (17bp deletion) (19bp deletion) 1
Excision sites were sequenced using primers outside the transposon. Short lines indicate the lost nucleotides. Footprint sequences are organized in
several categories. Canonical footprints have 7-bp sequences of TACAGTA or TACTGTA, conforming to the model illustrated in Figure 1B. Non-canonical
footprints have small deletions in the 7-bp canonical sequence. Gaps have larger deletions in either or both sides of the flanking sequence as indicated.
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Figure 3. PCR analysis of transposon excision from plasmids in
HeLa cells (A and B) and in zebrafish embryos (C). (A) Plasmids
with transposons and CMVSB transposase (pT/neo and pCMVSB)
were co-transfected into the HeLa cells. Cell lysate was obtained
for nested-PCR using primers outside the transposon. DDE
is a transposase without a catalytic domain. (B) Time-course
accumulation of excision products from HeLa cells. Hours
post-transfection are marked on top of the gel. Each time point
is represented by two separate transfections. The marker lane
(M) on the left of the gels in A and C is a 100-bp ladder
(New England Biolabs). (C) SB mRNA was co-injected into
one-cell-stage zebrafish embryos with plasmids containing a
transposon (pT/neo). Twenty-four hours after microinjection,
lysates from single embryos were used for PCR analysis. Two
different embryos were used in the last three categories.∗: pT/neo plasmids mixed with embryo lysate were used as
template in this case
the insertion TA site). Non-canonical footprints had small
deletions in the 7-bp canonical sequences. In the case of
HeLa cells, deletions were usually 2–3 bp. Gaps had large
deletions (17–89 bp) on either or both sides of the flank-
ing sequences. In one case, we observed a 20-bp insertion
of unknown origin between the two flanking sites. Most
of the footprints in zebrafish embryos were canonical
footprints, whereas the footprints in HeLa cells consisted
of similar percentages of canonical and non-canonical
footprints.
Excision activity correlates to
transposition activity
A preliminary study suggested that the excision activities
correlate to the transposition activity [16]. We examined
this hypothesis by measuring the excision activity of IR/DR
mutations shown to have different transposition rates to
evaluate its validity. To quantify the levels of excision, we
generated a set of standards using dilutions of the excision
lysate of the original pT/HindIIIneo. As the control for
the total input template, we used the amplification of
a segment in the backbone of both pT and pCMVSB
plasmids. For each gel scan, we first standardized the
intensity of the excision bands (in arbitrary increments of
density units, IOD) by dividing the IOD of the excision
bands by the relative amount of total input plasmid.
A standard curve was generated from the standardized
IOD values of the amplification products resulting from
dilutions of the standard pT/HindIIIneo. The relative
excision activity for each reaction was calculated as
a percentage of the pT/HindIIIneo activity. Figure 4
shows one example of a gel scan and the quantification
of the excision footprints. We compared these relative
excision activities with the earlier reported transposition
rates measured by a transposition assay [16]. In this
assay, transposon-mediated chromosome integration was
indicated by the increase in the number of G418-resistant
colonies, and the transposition rate was measured
as the percentage of the pT/HindIIIneo activity. The
comparisons of the activities of transposition and excision
are summarized in Table 2. Mutations with high excision
activities correlated with high transposition activities
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and mutations with low excision activities correlated
with low transposition activities. Although transposition
activities varied between parallel experiments, the relative
excision activities approximated transposition rates within
the uncertainties of our measurements, suggesting that
excision can be used as an indicator of transposition
efficiency and thereby for improvement of the SB
system.
Use of the excision assay to improve
the SB transposon system
The outer and inner DRs have different roles in excision
and transposon can be excised efficiently only at the outer
DRs [16]. These results suggested that it is not the location
but the differences in sequence between Lo and Li that
gives them different functional roles. Comparison of the
Table 2. Comparison of relative excision activity and relative
transposition rates
Constructs
Relative excision
activity
Relative
transposition rate
LoLi − RiRo + DDE nd 4% (1%)∗
LoLi − RiRo 100% 100% (30%)
RoRi − RiRo 42% 29% (6%)
LoLi − LiLo 95% 101% (30%)
LiLi − RiRo nd 4% (1%)∗
LoLo − RiRo 46% 43% (23%)
Relative excision activities were measured as described in Figure 4. The
relative transposition rates were determined as described in Cui et al.
[16]. Transposition rates are averages of four to seven independent
transfections, numbers in parentheses show the 95% confidence
interval. nd, non-detectable; ∗, background level of colony number.
LoLiRiRo is pT/Hindillneo.
Figure 4. Quantification of relative excision activity in HeLa
cell excision assay. Excision levels of four IR/DR mutations
were measured relative to the activity of LoLi–RiRo (the
pT/HindIIIneo transposon). The top gel shows excision PCR
products run on a 6% polyacrylamide gel stained with SYBR
green I. The lower gel shows PCR amplification of a segment
of the backbone of pT/neo and pCMVSB (or pSB10-DDE) as
an input control for the total plasmid in the lysate. The relative
excision abundancewasmeasured as a ratio of the band intensity
of the excision PCR products to that of the amplification of the
segment on the plasmid backbone. ‘‘Rel. template’’ indicates the
relative amount of the input lysate. Relative excision activity
(‘‘Rel. activity’’) is indicated as a percentage of control activity
using the ratio for each mutation compared to a standard curve
derived from the ratio of the different dilutions of the original
pT/HindIIIneo activity. ND, non-detectable
Lo and Li sequences showed that there are two discrete
regions in Lo that are different from Li, regions I and
II (Figure 5A). To determine which region is critical for
excision, we made mutations in each and tested whether
the excision activity was impaired.
We focused on two positions in region I because the
model in Figure 1 predicts that the C in the first position
(C1) and the G in the third position (G3) at the tip of
Lo and Ro demarcate the staggered cuts. These positions,
which are the same on the left and right IRs, should thus
be vital to the overall interaction between transposon
and transposase in this region. If true, changing the
nucleotides at these two positions should affect this
interaction and cause reduced excision activity. Figure 5B
is a detailed analysis of positions C1 and G3 in Lo and Ro.
In Lo, when we changed either C1 or G3, excision activity
was reduced to 11 and 18%, respectively, indicating that
both C1 and G3 contribute to excision activity. The double
mutation at both +1 and +3 reduced excision activity to
below the limit of detection. The same mutations were
made in Ro and the effects were similar, indicating that
these positions have the same functions on both sides.
These data suggest that the nucleotides in the first and
the third positions at the termini of the outer DRs in
region I are critical for excision.
We tested the requirement for region II by mutating
three out of the five terminal basepairs (TTAAG to
GGGAG). Comparison of Figure 5C lanes 1 and 2 indicated
that the exact sequence of region II was not critical for
excision because mutating these three base pairs did
TT
AA
G(p
T)
GG
GA
G
M
1 2
C
B
A
Figure 5. Terminal nucleotides in the outer DRs are important
for excision. (A) Sequence comparison of Lo and Li. Mutated
sequences in regions I and II are underlined. (B) Mutations in
region I at the first and third positions at the terminus of Lo are
underlined. Lo(CAG)Li–Ri(CTG)Ro indicate the pT/HindIIIneo
transposon. Quantification of the excision activity is as described
in Figure 4. ND, non-detectable. (C) Mutations in region II
wherein three out of the five terminal base pairs (TTAAG to
GGGAG) were changed
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not reduce excision activity. Instead, the excision activity
seems to have been increased. The band intensity for
the GGGAG mutation construct was eight times more
intense than that of the pT (TTAAG), which exceeded
the limit of our detection method. This trend persisted
in repeated experiments, leading us to incorporate these
mutations in the next generation of improved transposon
DNA (unpublished).
TA-dinucleotides flanking the
transposon affect excision
The TA-dinucleotides flanking the transposon are of
special interest. SB transposons insert only into TA-
dinucleotides, where a target-site duplication event leads
to TA flanks on both sides of the transposon [1]. This
raised the question of whether there is a functional
requirement for TA in excision. We examined this
question by replacing the TA-dinucleotides flanking the
transposon. We found that excision can still occur when
only one flanking TA is present, although activity is
dramatically reduced. When we replaced both TAs, the
excision rate was reduced to below the limit of detection
(Figure 6A). These results show that the TAs flanking the
transposon are strongly involved in excision and confirm
our earlier finding of their importance in the overall
transposition process [16]. We were able to acquire
complete footprints from the two mutation constructs
lacking TA on one side (Figure 6B). The footprints showed
that when GG replaced the TA outside the outer DR, the
substitution remained in the footprints (underlined GGs
in Figure 6B).
Use of the excision assay to evaluate SB
activity in adult animals
The SB transposon system has been used for gene
transfer into mice as a model for use in human gene
therapy [10–12]. However, evaluating the efficacy of
transposition is difficult because delivery of transposons
to many different cells of an organ results in integration
events in different sites of various chromosomes. Hence,
we examined whether the excision assay could be used
for this purpose.
We used the hydrodynamic delivery method of Liu et al.
[21] and Zhang et al. [22] to deliver an SB transposon to
MPS VII mice that were completely deficient in lysosomal
hydrolase β-glucuronidase [23]. The transposon plasmid
we constructed contained an expression cassette for
β-glucuronidase CAGGS-GUSB (Aronovich et al., in
preparation). Two groups of mice were injected with
pT/CAGGS-GUSB: Treatment Group 1 received only
the transposon-containing plasmid, Treatment Group 2
was co-injected with pCMVSB plasmid at a molar ratio
of 10 : 1 transposon/transposase. As in zebrafish, we
detected excision events only when both transposon and
transposase were injected (Figure 7). The PCR bands
were excised from the gel for cloning and sequencing
as described in the previous section. The predominant
band of 456 bp yielded eight readable sequences, seven
of which gave canonical footprints of TAC(A/T)GTA
(Table 4), similar to those found in zebrafish embryos
and mouse ES cells (Table 3) and one of which appeared
to be a transposition event using an alternative TA
excision site. Another six events were sequenced from
smaller, minor bands that showed deletions of various
sizes and nucleotide sequences that indicated illegitimate
B
A
Figure 6. Effect of TA-dinucleotides on excision. (A) Excision analysis of TA mutations on either side and both sides of the
transposon. TA Lo-RoTA indicates the pT/HindIIIneo transposon. Mutations are underlined. (B) Sequences of the excision site of
the mutated transposons. The footprints are underlined. ND, non-detectable
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Table 3. Comparison of SB footprints in different systems
Canonical
Non-canonical
footprint missing Gaps/ Total
footprint 1 bp 2 bp 3 bp Insertions events Reference
HeLa cell cultures 35% 0 18% 29% 18% 17 This study
Zebrafish embryos 96% 0 0 0 4% 25 This study and [g]
Mouse spermatids 0 31% 44% 0 25% 16 [4]
Mouse ES cells 85% 0 0 8% 8% 13 [14]
Mouse Livers 88% 0 0 0 12% 8 This study
Table 4. Footprint sequences from mouse livers
Left-flanking Footprint Right-flanking Events
Major Band of expected size ∼456 bp
Canonical GACTCACTATAGGGCGAATTGGAGCTCGGTACCC TA CAG TA GGGGATCCTCTAGCTAGAGT 6
footprints GACTCACTATAGGGCGAATTGGAGCTCGGTACCC TA CTG TA GGGGATCCTCTAGCTAGAGT 1
Gaps GACTCACTA- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - TAGAGT 1
Minor Bands of smaller size
(82 bp deletion) - - - - - - - (36 bp deletion) 1
Deletions (87 bp deletion) - - - - - - - (40 bp deletion) 1
(96 bp deletion) - - - - - - - (76 bp deletion) 1
Random 54 bp upstream of left TA, sequence continues at right ITR. 1
insertion 78 bp upstream of left TA 1
82 bp upstream of left TA continues into the complementary strand 44 bp downstream the right TA 1
500
1 2 3 4
400
Figure 7. Excision products in the livers of SB-transposon-trea-
ted MPS VII mice. Lane 1, 100-bp interval markers; lane
2, treatment with pT/CAGGS-GUSB alone; lane 3, treatment
with pT/CAGGS-GUSB + pCMVSB, lane 4, sham-treatment with
pBluscript
recombination that did not use SB transposase. Taken
together, the data suggest that the excision assay is useful
for quickly evaluating transposition of transgenes into
organs and tissues of living animals.
Discussion
We developed a plasmid-based excision assay for
Sleeping Beauty (SB)-mediated transposition and confirm
preliminary findings that suggested that excision rates
correlate to transposition rates. Here we have used
the excision assay as a simplified method to determine
the outcome of the multi-step transposition process
and to facilitate our understanding of the cis-elements
required for SB excision. This PCR-based excision assay is
independent of the transposon content and has shown that
the excision assay can be used to monitor transposition
in systems wherein drug selection is not feasible, such as
in non-dividing cells of whole animal tissues. Thus, the
excision assay offers a high-throughput means to detect
and measure transposition in somatic tissues in which
multiple transposition events occur in a large number of
cells.
The excision assay was used to elucidate several param-
eters of transposition that have not been appreciated
before. The first involves footprints left in the exci-
sion site. The ability to revert the transposition event
after remobilization of the transposon is one potential
advantage of using transposable elements in functional
genomics. Consequently, it is important to know whether
the footprint left after excision would maintain the open
reading frame for translation. Two previous studies have
provided conflicting results regarding the SB footprint.
Luo et al. [14] observed canonical footprints in mouse
embryonic stem cells, whereas Fischer et al. [4] observed
non-canonical footprints in mouse haploid spermatids. In
this study, we determined the footprints in tissue-cultured
cells and whole animals. As summarized in Table 3, in
HeLa cells there is a mixture of canonical footprints and
non-canonical footprints. In zebrafish, mouse embryonic
stem cells and mouse liver cells, most footprints are canon-
ical. In haploid spermatids, none of the footprints were
canonical. Together, these results show that SB leaves dif-
ferent footprints in different cell types and that the ability
Copyright  2004 John Wiley & Sons, Ltd. J Gene Med 2004; 6: 574–583.
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to revert to wild type after remobilization may be lim-
ited by the cell or tissue type. In zebrafish embryos, and
mouse embryonic stem cells and cells of the adult liver,
90% of the footprints add 5 bp (TA + CAG or CTG) to the
open reading frame, which should cause a frame shift.
In mouse haploid spermatids, over 40% of the footprints
add only 3 bp, which would allow reversion to the wild-
type phenotype. Thus, for experimental studies, reversion
to wild type would be rare when using SB in zebrafish
embryos, mouse embryonic stem cells, and tissues in mice.
The footprint data also showed that when GG replaced
the TA outside the outer DR, the substitution remained
in the footprints. This supports the current model that
the TA nucleotides flanking the transposon are not part
of the transposon and are not carried over into a target
site.
Double-strand breaks generated by transposon excision
are thought to be repaired by a process called non-
homologous end-joining [4]. In vertebrates, this process
is catalyzed by a group of enzymes including Ku70 and
Ku80 end-binding factors, the catalytic subunit of DNA-
dependent protein kinase (DNA-PK), and the XRCC4/DNA
ligase IV heteromeric complex. Mutation studies in yeast
have shown that loss of different subsets of these enzymes
leads to different repair products, including accurate
repair, inaccurate repair, and a mixture of accurate
and inaccurate repair [24]. These results resemble the
different footprint patterns we observed in different cell
types – mostly canonical footprints in zebrafish cells as
well as mouse embryonic stem cells and liver cells, non-
canonical footprints in mouse haploid spermatids, and a
mixture of canonical and non-canonical footprints in HeLa
cells. We suspect that the DNA repair machineries differ
in some way that leaves characteristic footprints for each
cell type. This hypothesis could be further investigated by
examining SB footprints in cell lines with known repair
defects.
The excision step we studied here is one of the major
steps involved in transposition. Studies from other DNA
transposons such as Tn10, Tn5 and Mu have identified the
detailed steps of transposition. Specifically, excision of the
transposon consists of transposase-binding to the terminal
repeats followed by formation of a synaptic complex
comprising the transposon–transposase. For the Mu
transposon, this step is called transpososome assembly.
The cut-and-paste reaction then occurs with first-strand
nicking, hairpin formation and hairpin resolution, which
releases the transposon from the donor site, and marks
the end of the excision step. Biochemical studies in
these systems have shown that the terminal nucleotides
at the transposon-donor junction are involved in steps
subsequent to DNA binding but before excision. In Mu, the
terminal nucleotides at the transposon-junction sequences
are involved in transpososome assembly [26,27]. In Tn5,
the end sequences are specifically required for synaptic
complex formation [28]. In Tn10, mutations in these
nucleotides prevent hairpin formation and strand transfer
[25]. In SB-mediated transposition, mutations in terminal
nucleotides do not affect transposase binding, but do
affect excision activity, indicating they may have a similar
function subsequent to DNA binding but before excision
as with other DNA transposons.
Our study of nucleotides bordering the sites of excision
both inside and outside the transposon suggests that the
requirement of transposon-donor junction nucleotides for
excision is not base-pair specific. Replacement of the TA-
dinucleotide, or of single nucleotides at the end of the
transposon, reduced but did not abolish excision activity.
These nucleotides may work synergistically. Whereas
point mutation at either position 1 or 3 at the end
of the left IR reduced relative excision activity to 11
and 18%, respectively, the double mutation reduced
the relative excision activity below the detectable limit,
about 5% (11% × 18% < 5%). These results suggest
that the nucleotides in this region may contribute to
a certain environment to affect transposon–transposase
interactions. This environment could have certain physical
properties required for transposase catalytic activity,
similar to the one observed at the target site [15,17;
G. Liu, in preparation]. Perturbing these interactions
would result in a less favorable environment that would
lead to a decrease in the rate of excision and an
approximately equal decrease in the rate of transposition.
If this hypothesis is true, then the flanking sequence of the
transposon outside the TA-dinucleotides might influence
transposon activity as well. Thus, with the excision assay,
we should be able to improve further the flanking sites,
which, like improving the activity of SB transposase [13],
should lead to more a more powerful transposon system.
Our results have considerable potential for developing
non-viral, transposon-mediated, gene-transfer vectors
for human therapy. At present, the only method
for evaluation of transposition events in organs of
multi-cellular animals is to sequence insertion sites in
chromosomes of treated animals because each cell in
which the transposon integrates is a separate event
that is non-clonal. This procedure is exceptionally labor-
intensive and non-quantitative. In contrast, by employing
the excision assay a few days after gene transfer,
investigators will be able to approximate efficiently and
quickly the levels of transposition into chromosomes of a
multi-cellular organ. Thus, the excision assay should be
extremely useful for evaluation of parameters affecting
gene delivery using plasmids as donor vehicles.
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